BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.0790
+0.0030 (3.95%)
Jul 17, 2026, 1:45 PM AEST
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 29.13 million as of July 17, 2026. Its market cap has increased by 15.34% in one year.
Market Cap
29.13M
Enterprise Value
29.24M
Revenue
2.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
ChartMarket Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 29.13M, a decrease of -43.68%. That is a compound annual growth rate of -10.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 29.13M | -24.64% |
| Dec 31, 2025 | 38.65M | 8.87% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
| Jul 21, 2021 | 51.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 437.83M |
| Healius | 272.31M |
| Monash IVF Group | 268.85M |
| Cryosite | 63.45M |
| Rhythm Biosciences | 30.79M |
| INOVIQ | 29.56M |
| Microba Life Sciences | 26.79M |
| ImExHS | 16.76M |